OrbiMed (New York), an investment firm focused on the healthcare sector, reported the closing of its second healthcare royalty and credit opportunities fund, OrbiMed Royalty Opportunities II, LP, with $924 million in commitments, including $24 million from the General Partner. Investors in the fund include a broad range of premier endowment, foundation, pension and other institutional investors.
Read More
